	US 11,674,129 B2
	Glucose isomerase
Birgit Brucher, Leipzig (DE); Andreas Vogel, Leipzig (DE); Hanna Maria Dudek, Leipzig (DE); and Rico Czaja, Leipzig (DE)
Assigned to NEW MATTERHORN, LLC, Wilmington, DE (US); and C-LEcta GmbH, Leipzig (DE)
Filed by C-LEcta GmbH, Leipzig (DE); and New Matterhorn, LLC, Wilmington, DE (US)
Filed on Jun. 9, 2021, as Appl. No. 17/303,882.
Application 17/303,882 is a continuation of application No. 16/610,373, granted, now 11,066,659, previously published as PCT/EP2018/061573, filed on May 4, 2018.
Claims priority of application No. 17000785 (EP), filed on May 5, 2017.
Prior Publication US 2021/0317432 A1, Oct. 14, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/92 (2006.01); C12P 19/02 (2006.01); C12P 19/24 (2006.01)

CPC C12N 9/92 (2013.01) [C12P 19/02 (2013.01); C12P 19/24 (2013.01)]

19 Claims

1. A polypeptide comprising an amino acid sequence, wherein the amino acid sequence of the polypeptide is at least 96% identical to the amino acid sequence of SEQ ID NO: 1, wherein the amino acid sequence of the polypeptide comprises an amino acid substitution at one or more amino acid positions, wherein each of the one or more amino acid positions is independently selected from the group consisting of SEQ ID NO: 1 amino acid positions 33 and 95.